MacroGenics
MGNX
#9393
Rank
A$0.13 B
Marketcap
A$2.06
Share price
-0.72%
Change (1 day)
-60.76%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): A-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.07527. In 2024 the company made an earnings per share (EPS) of A-$1.61 a decrease over its 2023 EPS that were of A-$0.23.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.20-87.7%
2024A-$1.61613.33%
2023A-$0.23-92.31%
2022A-$2.94-42.14%
2021A-$5.0736.44%
2020A-$3.72-21.84%
2019A-$4.76-24.58%
2018A-$6.31675.93%
2017A-$0.81-68.05%
2016A-$2.54168.25%
2015A-$0.95-55%
2014A-$2.113400%
2013A-$0.06022-108.68%
2012A$0.6924.49%
2011A$0.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
A-$2.66 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.59-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.43-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.82-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$19.62-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$30.89-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.47-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA